MarketInOut Stock Screener Log In | Sign Up
 

Novartis AG

OTC • Healthcare • Drug Manufacturers - General • Quote as of 08/11/2026
Novartis AG stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeOTC
Market Capitalization288,757 mln
Float1,856 mln
Earnings Date10/27/2026

EPS

6.62
Strong

P / E

23.85
Premium valuation

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-2.7
Likely reliable

Relative Strength

61 / 100
Outperforming

Debt / Equity

1.18
Elevated leverage

Business Description

Novartis AG is a Swiss pharmaceutical company founded in 1996 and based in Basel, with operations spanning dozens of countries worldwide. The company researches, develops, and sells a broad range of medicines targeting serious conditions such as heart disease, cancer, immune disorders, and neurological conditions. Its product lineup includes well-known treatments like Entresto for heart failure, Cosentyx for inflammatory diseases, Kisqali for certain cancers, and Zolgensma for spinal muscular atrophy, among many others.

Key Fundamentals

EPS6.62
P/E23.85
ROE30.02
RPS29.42
ROIC12.97
ROA11.33
Interest Cover12.30
EBITDA, mln22,455
EV / EBITDA14.88
EV / EBIT19.75
Revenue, mln56,693
EV / Revenue5.89

Financial Strength

Altman Z-Score3.64
Piotroski F-Score 5 / 9
Beneish M-Score-2.7
Shiller PE Ratio23.81

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 2.22% 57 / 100   
1 Month 8.98% 70 / 100   
2 Months 6.81% 64 / 100   
6 Months 29.75% 81 / 100   
1 Year 51.82% 75 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us